14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BIM.PA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of bioMérieux S.A. stock downgraded after the last trading session.
(Updated on Apr 24, 2024)

Buy or Hold candidate since Apr 23, 2024 Loss -0.69% PDF

The bioMérieux S.A. stock price fell by -0.690% on the last day (Wednesday, 24th Apr 2024) from 101.40€ to 100.70€. During the last trading day the stock fluctuated 1.89% from a day low at 100.70€ to a day high of 102.60€. The price has been going up and down for this period, and there has been a -3.36% loss for the last 2 weeks. Volume has increased on the last day by 12 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 97 thousand shares were bought and sold for approximately 9.81€ million.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect bioMérieux S.A. stock with a 90% probability to be traded between 93.62€ and 104.63€ at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BIM.PA Signals & Forecast

The bioMérieux S.A. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at 100.42€ and 100.46€. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 1.72%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The stock had a Golden Star Signal on Tuesday, August 22, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Tuesday, August 22, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for bioMérieux S.A. stock

bioMérieux S.A. finds support from accumulated volume at 100.60€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved 1.90€ between high and low, or 1.89%. For the last week, the stock has had daily average volatility of 1.91%.

Our recommended stop-loss: 96.38€ (-4.29%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (BIM.PA) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect bioMérieux S.A. to open at 101.33€, and during the day (based on 14 day Average True Range), to move between 97.95€ and 103.45€, which gives a possible trading interval of +/-2.75€ (+/-2.73%) up or down from last closing price. If bioMérieux S.A. takes out the full calculated possible swing range there will be an estimated 5.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 100.60€ (0.10%) than the resistance at 101.10€ (0.40%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is bioMérieux S.A. stock A Buy?

bioMérieux S.A. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.764 Hold/Accumulate Downgraded

Predicted Opening Price for bioMérieux S.A. of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
101.33€ ( 0.629%) 100.70€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BIM.PA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 103.23 2.52 %
R2 102.51 1.79 %
R1 102.06 1.35 %
Current price: 100.70
Support S1 100.61 -0.0918 %
S2 100.16 -0.537 %
S3 99.43 -1.26 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 106.20 5.46 %
R2 104.20 3.48 %
R1 101.10 0.397 %
Current price 100.70
Support S1 100.60 -0.0993%
S2 100.35 -0.348%
S3 97.68 -3.00%

BIM Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 07, 2024 Jun 07, 2024 Jun 11, 2024 0.85€ 0.84%
2 Jun 06, 2023 Jun 06, 2023 Jun 06, 2023 0.85€ 0.89%
3 Jun 06, 2022 Jun 06, 2022 Jun 06, 2022 0.85€ 0.89%
4 Jun 04, 2021 Jun 04, 2021 Jun 04, 2021 0.620€ 0.678%
5 Feb 26, 2020 Jul 14, 2020 Jul 16, 2020 0.190€ 0.144%

FAQ

What is the symbol for bioMérieux S.A. Stock and on which exchange is it traded?
The symbol for bioMérieux S.A. is BIM.PA and it is traded on the PAR (Euronext Paris).

Should I buy or sell bioMérieux S.A. Stock?
bioMérieux S.A. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy bioMérieux S.A. Stock?
bioMérieux S.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy bioMérieux S.A. Stock.

What's the current price of bioMérieux S.A. Stock?
As of the end of day on the Apr 24, 2024, the price of an bioMérieux S.A. (BIM.PA) share was 100.70€.

What is the 52-week high and low for bioMérieux S.A. Stock?
The 52-week high for bioMérieux S.A. Stock is 108.90€ and the 52-week low is 84.54€.

What is the market capitalization of bioMérieux S.A. Stock?
As of the Apr 24, 2024, the market capitalization of bioMérieux S.A. is 11.898B.

When is the next earnings date for bioMérieux S.A.?
The upcoming earnings date for bioMérieux S.A. is Sep 05, 2024.
Click to get the best stock tips daily for free!

About bioMérieux S.A.

bioMérieux S.A. bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves cli... BIM.PA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT